From: Severe hyperkalemia requiring hospitalization: predictors of mortality
Number (percentage) | Univariate analysis | Multiple logistic regression analysisa | ||||
---|---|---|---|---|---|---|
In-hospital mortality group | Survival group | OR (95% CI) | P | OR (95% CI) | P | |
Modifiable factors | ||||||
Drug-induced hyperkalemiab | ||||||
ACEi | 7 (2.5) | 53 (8.3) | 0.28 (0.13-0.63) | 0.002 | ||
ARB | 19 (6.7) | 146 (22.8) | 0.24 (0.15-0.40) | < 0.001 | ||
Beta blocker | 17 (6.0) | 107 (16.7) | 0.32 (0.19-0.54) | < 0.001 | 0.31 (0.13-0.74) | 0.009 |
K+-sparing diuretics | 20 (7.1) | 88 (13.8) | 0.48 (0.29-0.79) | 0.004 | ||
NSAIDs | 2 (0.7) | 20 (3.1) | 0.22 (0.05-0.95) | 0.043 | ||
Digoxin | 9 (3.2) | 16 (2.5) | 1.28 (0.56-2.94) | 0.558 | ||
K supplementsb | 38 (13.4) | 91 (14.2) | 0.94 (0.62-1.41) | 0.749 | ||
Non-modifiable factors | ||||||
ECG findings pertinent to hyperkalemia | ||||||
No changes | 23 (8.7) | 169 (41.3) | Reference | |||
Atypical findings | 45 (17.0) | 97 (23.7) | 3.37 (1.93-5.88) | < 0.001 | ||
Typical findings | 196 (74.2) | 143 (35.0) | 9.36 (5.80-15.10) | < 0.001 |